Your partner in personalised medicine.
Early risk assessment through genetic testing supports a more personalised management of individual health. The geneType tests help develop personalised, preventative health plans for your patients. By integrating your patient’s clinical, familial and genetic data, we deliver a personalised score for their risk of serious conditions. What’s more, we help you interpret your patient’s results in the context of your local guidelines.
Take the first step towards personalised, preventative healthcare
Knowing your patients’ personalised risk enables you to develop a health plan with them to reduce their risk of serious disease. Select from the tests below to take the first step to managing your patients’ risk.
Breast Cancer
Find out if your patients are at increased risk of developing breast cancer
Colorectal Cancer
Find out if your patients are at increased risk of developing bowel (colorectal) cancer
Ovarian Cancer
Find out if your patients are at increased risk of developing a ovarian cancer
Prostate Cancer
Find out if your patients are at increased risk of developing a prostate cancer
Coronary Artery Disease
Find out if your patients are at increased risk of developing coronary artery disease
Type 2 Diabetes
Find out if your patients are at increased risk of developing type 2 diabetes
Multi-Risk Test
Find out if your patients are at increased risk of developing a wide range of cancers as well as heart disease and type 2 diabetes
One report.
Actionable insights.
We provide a comprehensive risk assessment report that will assist you in developing a personalised health plan for your patients.
Key features of a geneType report include:
- Quick identification of your patient’s lifetime risk score and 5-, 8- or 10-year risk depending on the condition.
- Interpretation of these risk scores in the context of your local guideline recommendations to assist with clinical decision making about screening and risk-reducing strategies.
- A polygenic risk score: this score is based on genetic data and is integrated into the overall risk score. It is typically not included in traditional risk assessment models.
Sample patient report
Scientific Advisory Board
To ensure our tests are of the highest clinical value, geneType has enlisted the experience and expertise of senior scientific and medical leaders from around the world. They help us tailor our tests to reflect the strongest scientific evidence. Together can advance the field. personalised, preventative health solutions.
Professor Jon Emery
MBBCh MA DPhil FRACGP MRCGP
Research & Education Lead, Primary Care Integration, Victorian Comprehensive Cancer Centre Herman Chair of Primary Care Cancer Research, University of Melbourne
Professor Finlay Macrae AO
MBBS, MD, FRACP, FRCP, AGAF MWGO
Principal Fellow and Professor, Department of Medicine, University of Melbourne, and Head of Colorectal Medicine and Genetics, The Royal Melbourne Hospital
Dr. Ora K. Gordon
MD, MS, FACMG
Regional Medical Director, Center for Clinical Genetics & Genomics. Clinical Director, PSJH Population Health Genomics Program. Chair, Integrated Network Cancer Program, Professor of Genetics, St John Cancer Institute
 Testing is simple
Step 1
Register as a provider; our team will provide clinical education and other resources as needed.
geneType will send kits to your clinic to have on hand.
Step 2
Discuss geneType with your patient.
Would geneType help them qualify for additional risk reduction strategies?
Step 3
Complete the Test Requisition form, collect a sample from the patient in the buccal swabs provided and return both to geneType.
You will have the option to use a paper requisition, or a secure, compliant portal to complete the ordering process.
Step 4
Leave the rest to us.
geneType will notify you when your patient’s results are ready.
You will have the option to request a consult with a genetic counsellor, whether to review your patient’s results and/or to follow-up with your patient, as needed.
*Patient eligibility dependent on personal medical history, age and sex
Interested in ordering more than one disease? Order geneType Multi-Test.
See individual disease pages for more information about each test.
The Multi-Risk suite of tests is for adults 40-85 years of age. At maximum, a woman would be eligible for 8 diseases in the panel; a man would be eligible for 7. Starting at age 30, a patient may qualify for geneType's cancer risk assessments only.
A genetic counsellor
on your team.
A genetic counsellor is available to help your geneType patients understand the geneType test and interpret their results.
For medical practitioners who order geneType test, you and your patients have the option to speak with a genetic counsellor when their results are ready.
For patients who order through our telehealth partner, they need to speak with our genetic counsellor to have their results released.
Our goal is to support both medical practitioners and patients through this journey. This is not a test-and-forget approach.
If you have technical questions, or questions around a patient’s clinical report, our genetic counsellor and Medical Affairs Team is available to you.
Are you ready to get started with geneType?
The first step is to setup an account to trial geneType at your practice.
Accredited For Compliance With NPAAC Standards And ISO 15189
